Breitfeld Philip P. 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Oct 14, 2022
Insider Transaction Report
Form 4
Breitfeld Philip P.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-10-12$3.21/sh+8,333$26,749→ 18,200 total - Tax Payment
Common Stock
2022-10-12$7.51/sh−3,562$26,751→ 14,638 total - Exercise/Conversion
Option to purchase Common Stock
2022-10-12−8,333→ 0 totalExercise: $3.21Exp: 2022-10-31→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022.
- [F2]The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018